| Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 KL Ong, LK Stafford, SA McLaughlin, EJ Boyko, SE Vollset, AE Smith, ... The Lancet 402 (10397), 203-234, 2023 | 4171 | 2023 |
| Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in … AJ Ferrari, DF Santomauro, A Aali, YH Abate, C Abbafati, H Abbastabar, ... The Lancet 403 (10440), 2133-2161, 2024 | 2566 | 2024 |
| Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the … M Naghavi, KL Ong, A Aali, HS Ababneh, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2100-2132, 2024 | 2044 | 2024 |
| Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease … M Brauer, GA Roth, AY Aravkin, P Zheng, KH Abate, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2162-2203, 2024 | 1981 | 2024 |
| Global burden of cardiovascular diseases and risks, 1990-2022 GA Mensah, V Fuster, CJL Murray, GA Roth, YH Abate, M Abbasian, ... Journal of the American College of Cardiology 82 (25), 2350-2473, 2023 | 1378 | 2023 |
| Long-Term Trends in First Hospitalization for Heart Failure and Subsequent Survival Between 1986 and 2003: A Population Study of 5.1 Million People PS Jhund, K MacIntyre, CR Simpson, JD Lewsey, S Stewart, A Redpath, ... Circulation 119 (4), 515-523, 2009 | 864 | 2009 |
| Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 SE Vollset, HS Ababneh, YH Abate, C Abbafati, R Abbasgholizadeh, ... The Lancet 403 (10440), 2204-2256, 2024 | 831* | 2024 |
| Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, HH Kyu, A Aali, C Abbafati, J Abbas, ... The Lancet 403 (10440), 1989-2056, 2024 | 766 | 2024 |
| Global burden of chronic respiratory diseases and risk factors, 1990–2019: an update from the Global Burden of Disease Study 2019 S Momtazmanesh, SS Moghaddam, SH Ghamari, EM Rad, N Rezaei, ... EClinicalMedicine 59, 2023 | 704 | 2023 |
| Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study E Vasileiou, CR Simpson, T Shi, S Kerr, U Agrawal, A Akbari, S Bedston, ... The Lancet 397 (10285), 1646-1657, 2021 | 689 | 2021 |
| The epidemiology, healthcare and societal burden and costs of asthma in the UK and its member nations: analyses of standalone and linked national databases M Mukherjee, A Stoddart, RP Gupta, BI Nwaru, A Farr, M Heaven, ... BMC medicine 14 (1), 113, 2016 | 380 | 2016 |
| Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: a systematic analysis for the Global … YH Shin, J Hwang, R Kwon, SW Lee, MS Kim, ... Allergy 78 (8), 2232-2254, 2023 | 362 | 2023 |
| SARS-CoV-2 infection and COVID-19 vaccination rates in pregnant women in Scotland SJ Stock, J Carruthers, C Calvert, C Denny, J Donaghy, A Goulding, ... Nature medicine 28 (3), 504-512, 2022 | 351 | 2022 |
| Prevalence of polypharmacy in a Scottish primary care population RA Payne, AJ Avery, M Duerden, CL Saunders, CR Simpson, GA Abel European journal of clinical pharmacology 70 (5), 575-581, 2014 | 322 | 2014 |
| A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland NF Murphy, CR Simpson, PS Jhund, S Stewart, M Kirkpatrick, J Chalmers, ... Heart 93 (5), 606-612, 2007 | 314 | 2007 |
| First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland CR Simpson, T Shi, E Vasileiou, SV Katikireddi, S Kerr, E Moore, ... Nature medicine 27 (7), 1290-1297, 2021 | 297 | 2021 |
| High risk prescribing in primary care patients particularly vulnerable to adverse drug events: cross sectional population database analysis in Scottish general practice B Guthrie, C McCowan, P Davey, CR Simpson, T Dreischulte, K Barnett Bmj 342, 2011 | 292 | 2011 |
| Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019 HH Kyu, A Vongpradith, SB Sirota, A Novotney, CE Troeger, MC Doxey, ... The Lancet Infectious Diseases 22 (11), 1626-1647, 2022 | 290 | 2022 |
| A systematic review and individual patient data meta-analysis of prognostic factors for foot ulceration in people with diabetes: the international research collaboration for … F Crawford, G Cezard, FM Chappell, GD Murray, JF Price, A Sheikh, ... Health technology assessment (Winchester, England) 19 (57), 1, 2015 | 265 | 2015 |
| Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in … U Agrawal, S Bedston, C McCowan, J Oke, L Patterson, C Robertson, ... The Lancet 400 (10360), 1305-1320, 2022 | 256 | 2022 |
Chris RobertsonProfessor Public Health Epidemiology, Strathclyde UniversityVerified email at strath.ac.uk
